换一批
换一批The role of small molecule platelet-derived growth factor receptor (PDGFR) inhibitors in the treatment of neoplastic disorders.
第一作者：
Robert,Roskoski
第一单位：
Blue Ridge Institute for Medical Research, 3754 Brevard Road, Suite 116, Box 19, Horse Shoe, NC, 28742-8814, United States. Electronic address: rrj@brimr.org.
作者：
关键词
Axitinib: (PubMED CID: 6450551)Catalytic spineDasatinib: (PubMED CID: 3062316)Imatinib: (PubMED CID: 5291)K/E/D/DLenvatinib: (PubMED CID: 9823820)Nilotinib: (PubMed CID: 644241)Nintedanib: (PubMed CID: 9809715)Ponatinib: (PubMed CID: 24826799)Protein kinase inhibitor classificationProtein kinase structureRegulatory spineSorafenib: (PubMed CID: 216239)Sunitinib: (PubMed CID: 5329102)Targeted cancer therapy
主题词
动物(Animals);人类(Humans);配体(Ligands);肿瘤(Neoplasms);血小板源性生长因子(Platelet-Derived Growth Factor);蛋白激酶抑制剂(Protein Kinase Inhibitors);受体, 血小板源生长因子(Receptors, Platelet-Derived Growth Factor)
DOI
10.1016/j.phrs.2018.01.021
PMID
29408302
发布时间
2022-03-21
- 浏览2
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
